2.21
price down icon2.21%   -0.05
after-market  Handel nachbörslich:  2.16  -0.05   -2.26%
loading

Finanzdaten der Revelation Biosciences Inc-Aktie (REVB)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
18.22%
1.9021
2.3259 2.7779 1.933 1.6198
Operating Income/Loss
18.22%
-1.9021
-2.3259 -2.7779 -1.933 -1.6198
Nonoperating Income/Loss
733.64%
-0.7793
0.123 0.1495 0.4849 7.779
Income/Loss From Continuing Operations Before Tax
21.72%
-2.6814
-2.2029 -2.6284 -1.4482 6.1592
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
21.72%
-2.6814
-2.2029 -2.6284 -1.4482 6.1592
Net Income/Loss
21.72%
-2.6814
-2.2029 -2.6284 -1.4482 6.1592
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
123.54%
1.0898
-4.629 6.2973 5.8123 2.2107
Diluted Average Shares
122.73%
1.0898
-4.7955 6.2973 5.8123 3.1359
Basic Earnings Per Share
156.25%
-2.46
-0.96 -0.42 -0.25 2.79
Diluted Earnings Per Share
161.70%
-2.46
-0.94 -0.42 -0.25 1.96
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$83.51
price down icon 0.87%
$26.19
price down icon 0.83%
$162.58
price down icon 2.28%
$160.39
price up icon 0.21%
$92.08
price down icon 4.08%
$387.00
price down icon 0.35%
Kapitalisierung:     |  Volumen (24h):